We’re proud to have been a speciality pharmaceutical leader in liquid medicines for over 50 years.

Rosemont was established in 1967 by two pharmacists in response to the lack of liquid medicines available for their patients who couldn’t swallow tablets or capsules.

We have since continued to bring liquid medicines to market and advocate support for vulnerable patients with swallowing difficulties. In 1974, our first liquid medicine was granted a license from the MHRA. We have subsequently continued our commitment to research, developing more liquid medicines to support both healthcare professionals and their patients. We now have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products.

Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practices for the care of patients with swallowing difficulties.